
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Two-Stage SN38 Release from a Core–Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade
Xiaomin Jiang, Morten J. Lee, Junjie Xia, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 21417-21430
Open Access | Times Cited: 38
Xiaomin Jiang, Morten J. Lee, Junjie Xia, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 21417-21430
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Lipid Prodrug Nanoassemblies via Dynamic Covalent Boronates
Yuxun Ding, Xiaowen Hu, Yinzi Piao, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6601-6614
Closed Access | Times Cited: 42
Yuxun Ding, Xiaowen Hu, Yinzi Piao, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6601-6614
Closed Access | Times Cited: 42
Immunogenicity of Extracellular Vesicles
Yutian Xia, Jianzhong Zhang, Gang Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Open Access | Times Cited: 38
Yutian Xia, Jianzhong Zhang, Gang Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Open Access | Times Cited: 38
Research Progress of SN38 Drug Delivery System in Cancer Treatment
Qing-rui Qi, Huan Tian, Baosen Yue, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 945-964
Open Access | Times Cited: 13
Qing-rui Qi, Huan Tian, Baosen Yue, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 945-964
Open Access | Times Cited: 13
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 12
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 12
Metformin‐Mediated Immunosuppressive Microenvironment Remodeling in Combination with Chemotherapy via a Spatial‐Specific Multi‐Responsive Carrier‐Free Self‐Assembled Nanoparticle
Yujun Song, Yufan Du, Chuan Hu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 10
Yujun Song, Yufan Du, Chuan Hu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 10
Nanotherapeutics for prostate cancer treatment: A comprehensive review
Ruimin Hu, Lan Jin, Dinglin Zhang, et al.
Biomaterials (2024) Vol. 305, pp. 122469-122469
Closed Access | Times Cited: 9
Ruimin Hu, Lan Jin, Dinglin Zhang, et al.
Biomaterials (2024) Vol. 305, pp. 122469-122469
Closed Access | Times Cited: 9
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition
Xiaomin Jiang, Taokun Luo, Kaiting Yang, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 8
Xiaomin Jiang, Taokun Luo, Kaiting Yang, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 8
Camptothecin-based prodrug nanomedicines for cancer therapy
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Renshuai Zhang, Jing Yu, Zhu Guo, et al.
Nanoscale (2023) Vol. 15, Iss. 44, pp. 17658-17697
Closed Access | Times Cited: 19
Combination Therapy of Lox Inhibitor and Stimuli‐Responsive Drug for Mechanochemically Synergistic Breast Cancer Treatment
Shanshan Zhu, Tian Zhang, Huan Gao, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 21
Closed Access | Times Cited: 18
Shanshan Zhu, Tian Zhang, Huan Gao, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 21
Closed Access | Times Cited: 18
Ratiometric optical probes for biosensing
Xiao Yang, Congcong Li, Peifeng Li, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2632-2656
Open Access | Times Cited: 18
Xiao Yang, Congcong Li, Peifeng Li, et al.
Theranostics (2023) Vol. 13, Iss. 8, pp. 2632-2656
Open Access | Times Cited: 18
Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy
Shunzhe Zheng, Guanting Li, Jianbin Shi, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 819-846
Closed Access | Times Cited: 17
Shunzhe Zheng, Guanting Li, Jianbin Shi, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 819-846
Closed Access | Times Cited: 17
Enzyme/pH Dual-Responsive Engineered Nanoparticles for Improved Tumor Immuno-Chemotherapy
Zefeng Liu, Xiaohan Hao, Jieying Qian, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12951-12964
Closed Access | Times Cited: 7
Zefeng Liu, Xiaohan Hao, Jieying Qian, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 10, pp. 12951-12964
Closed Access | Times Cited: 7
Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7
Elucidation of Spatial Cooperativity in Chemo‐Immunotherapy by a Sequential Dual‐pH‐Responsive Drug Delivery System
Shihao Wang, Lifeng Liu, Limin Tian, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 7
Shihao Wang, Lifeng Liu, Limin Tian, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 7
Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy
Fengjuan Xie, Shasha Tang, Ye Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1690-1701
Closed Access | Times Cited: 6
Fengjuan Xie, Shasha Tang, Ye Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1690-1701
Closed Access | Times Cited: 6
Charge-reversal biodegradable nanoplatform with ferroptosis and ICD induction for tumor synergistic treatment
Ping Sun, Li Huang, Zimu Li, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149234-149234
Closed Access | Times Cited: 6
Ping Sun, Li Huang, Zimu Li, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149234-149234
Closed Access | Times Cited: 6
Platinum-based combination nanomedicines for cancer therapy
Youyou Li, Wenbin Lin
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102290-102290
Open Access | Times Cited: 15
Youyou Li, Wenbin Lin
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102290-102290
Open Access | Times Cited: 15
Calcium-Mediated Cell Adhesion Enhancement-Based Antimetastasis and Synergistic Antitumor Therapy by Conjugated Polymer–Calcium Composite Nanoparticles
Junni He, Yuze Wang, Yuxin Ren, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24953-24967
Closed Access | Times Cited: 5
Junni He, Yuze Wang, Yuxin Ren, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24953-24967
Closed Access | Times Cited: 5
Characterization and Evaluation Techniques for Core-Shell Nanoconstructs for Cancer Theragnostics
Ashish Kumar Parashar, Gaurav K. Saraogi, Vandana Arora Sethi
(2025), pp. 179-214
Closed Access
Ashish Kumar Parashar, Gaurav K. Saraogi, Vandana Arora Sethi
(2025), pp. 179-214
Closed Access
Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy
Zhi-Xin Zhong, Xu‐zhao Li, Jintao Liu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1281-1298
Open Access | Times Cited: 12
Zhi-Xin Zhong, Xu‐zhao Li, Jintao Liu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1281-1298
Open Access | Times Cited: 12
Nanoassembly of doxorubicin-conjugated polyphosphoester and siRNA simultaneously elicited macrophage- and T cell- mediated anticancer immune response for cancer therapy
Dongdong Li, Ziyang Cao, Chaoran Chen, et al.
Biomaterials (2023) Vol. 302, pp. 122339-122339
Closed Access | Times Cited: 12
Dongdong Li, Ziyang Cao, Chaoran Chen, et al.
Biomaterials (2023) Vol. 302, pp. 122339-122339
Closed Access | Times Cited: 12
NIR-IIb fluorescence antiangiogenesis copper nano-reaper for enhanced synergistic cancer therapy
Wenling Li, Huan Xin, Wenjuan Gao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Wenling Li, Huan Xin, Wenjuan Gao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis
Yi Mou, Shuai Wen, Yan Wang, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 325-325
Open Access
Yi Mou, Shuai Wen, Yan Wang, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 325-325
Open Access
Multi-functional lipid nanoformulations for enhancing the efficacy of mRNA tumor vaccines by reversing tumor immunosuppressive microenvironment
Yufeng Zhang, Liuwei Zhang, Hui Gao, et al.
Nano Today (2025) Vol. 63, pp. 102757-102757
Closed Access
Yufeng Zhang, Liuwei Zhang, Hui Gao, et al.
Nano Today (2025) Vol. 63, pp. 102757-102757
Closed Access
Co-delivery of three synergistic chemotherapeutics in a core-shell nanoscale coordination polymer for the treatment of pancreatic cancer
Xiaomin Jiang, Morten J. Lee, Taokun Luo, et al.
Biomaterials (2023) Vol. 301, pp. 122235-122235
Open Access | Times Cited: 10
Xiaomin Jiang, Morten J. Lee, Taokun Luo, et al.
Biomaterials (2023) Vol. 301, pp. 122235-122235
Open Access | Times Cited: 10